S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains

Organovo (ONVO) Earnings Date, Estimates & Call Transcripts

$1.12
-0.03 (-2.61%)
(As of 05:45 PM ET)

Earnings Summary

Upcoming
Earnings Date
Jul. 11Estimated
Actual EPS
(Feb. 8)
-$0.40 Beat By $0.01
Consensus EPS
(Feb. 8)
-$0.41
Skip Charts & View Estimated and Actual Earnings Data

ONVO Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ONVO Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Organovo Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20241($0.43)($0.43)($0.43)
Q3 20241($0.41)($0.41)($0.41)
Q4 20241($0.42)($0.42)($0.42)
20243($1.26)($1.26)($1.26)
Q1 20251($0.46)($0.46)($0.46)
Q2 20251($0.46)($0.46)($0.46)
Q3 20251($0.50)($0.50)($0.50)
Q4 20251($0.49)($0.49)($0.49)
FY 20254($1.91)($1.91)($1.91)
Q1 20261($0.45)($0.45)($0.45)
Q2 20261($0.45)($0.45)($0.45)

ONVO Earnings Date and Information

Organovo last announced its quarterly earnings data on February 8th, 2024. The medical research company reported ($0.40) EPS for the quarter, topping the consensus estimate of ($0.41) by $0.01. The business earned $0.01 million during the quarter, compared to analyst estimates of $0.08 million. Organovo has generated ($2.17) earnings per share over the last year (($2.17) diluted earnings per share). Earnings for Organovo are expected to grow in the coming year, from ($1.74) to ($1.41) per share. Organovo has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, July 11th, 2024 based off prior year's report dates.

Organovo Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
7/11/2024
Estimated)
------- 
2/8/2024Q3 2024($0.41)($0.40)+$0.01($0.40)$0.08 million$0.01 million
11/9/2023Q2 2024($0.43)($0.46)($0.03)($0.46)--
8/10/2023Q1 2024-($0.46)($0.46)($0.46)-$0.08 million
7/13/2023Q4 2023-($0.85)($0.85)($0.85)-$0.16 million
2/9/2023Q3 2023-($0.37)($0.37)($0.37)-$0.13 million
11/10/2022Q2 2023-($0.38)($0.38)($0.38)-$0.08 million
8/11/2022Q1 2023-($0.37)($0.37)($0.37)--
6/10/2022Q4 2022-($0.22)($0.22)($0.22)-$1.50 million
2/14/2022Q3 2022-($0.40)($0.40)($0.40)--
11/8/2021Q2 2022-($0.40)($0.40)($0.40)--
8/6/2021Q1 2022-($0.29)($0.29)($0.29)--
6/15/2021Q4 2021-($0.30)($0.30)($0.30)--

Organovo Earnings - Frequently Asked Questions

When is Organovo's earnings date?

Organovo has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, July 11th, 2024 based off last year's report dates. Learn more on ONVO's earnings history.

Did Organovo beat their earnings estimates last quarter?

In the previous quarter, Organovo (NASDAQ:ONVO) reported ($0.40) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.41) by $0.01. Learn more on analysts' earnings estimate vs. ONVO's actual earnings.

How much revenue does Organovo generate each year?

Organovo (NASDAQ:ONVO) has a recorded annual revenue of $370,000.00.

How much profit does Organovo generate each year?

Organovo (NASDAQ:ONVO) has a recorded net income of -$17.26 million. ONVO has generated -$2.17 earnings per share over the last four quarters.

What is Organovo's EPS forecast for next year?

Organovo's earnings are expected to grow from ($1.74) per share to ($1.41) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:ONVO) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners